Kg equivalents sold: 7,062.
Average retail selling price of medical cannabis per gram: 8.16; average selling price of adult-use cannabis per gram: 5.22.
Net loss: (7.9M) (-114.4%); loss/share: (0.03) (-113.6%); non-GAAP EBITDA: 1.9M (-120.0%).
The company received EU GMP compliance confirmation for ARA-Avanti Rx Analytics.
Irwin D. Simon, will officially remove "interim" from his title, effective today. Mr. Simon had been serving as Interim CEO since February 2019.
Fiscal 2020 guidance: Revenue: 575M - 625M (distribution revenue will represent slightly more than half) from 650M - 700M; non-GAAP EBITDA: approx. 35M - 42M from 88M - 95M.
Shares are up 2% premarket.
Try Seeking Alpha PREMIUM for unlimited analysis on APHA